# Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation

> **NCT03265496** · NA · TERMINATED · sponsor: **Centre Oscar Lambret** · enrollment: 21 (actual)

## Conditions studied

- Nsclc

## Interventions

- **PROCEDURE:** Clinical exam
- **PROCEDURE:** Liquid biopsy
- **PROCEDURE:** Diagnostic exam
- **DRUG:** 1st line treatment
- **PROCEDURE:** tumor evaluation
- **BIOLOGICAL:** Biopsy

## Key facts

- **NCT ID:** NCT03265496
- **Lead sponsor:** Centre Oscar Lambret
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-07-07
- **Primary completion:** 2021-04-13
- **Final completion:** 2021-04-13
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** The number of recruted patient was not sufficient
- **Last updated:** 2026-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03265496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03265496, "Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03265496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*